Drug screening--beyond the bottleneck.

Nature biotechnology ·Vol. 17 ·No. 9 ·1999-09-00 ·Pages 859-63

Dove A

Abstract

High-throughput screening still has a long way to go if it is to achieve its often-touted potential.

MeSH Terms

Commerce Drug Evaluation, Preclinical/economics,instrumentation Drug Industry/economics,instrumentation Oligonucleotide Array Sequence Analysis Technology, Pharmaceutical/economics,instrumentation

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Dove A

Article Info

Journal

Nature biotechnology

Abbr.

Nat Biotechnol

ISSN

1087-0156

DOI

10.1038/12845

Published

1999-09-00

Pages

859-63

Language

English

Region

United States

NLM ID

9604648

Subset

External Links

PubMed source DOI: 10.1038/12845 View journal details

Analysis Services

Drug screening--beyond the bottleneck.

Contact

WeChat Official Account